Share Trading Tips

Buy Yes Bank with a stop loss of Rs 302 for a target of Rs 349

Buy Titan Industrieswith a stop loss of Rs 2853 for a target of Rs 3300

Buy Andhra Bank around Rs 153.30-155.90, stop loss Rs 151, book profit at Rs 160.10-167

Sell Cipla around Rs 314.10-308.30, stop loss Rs 319, cover short at Rs 298.20-282.20

Tata Steel has announced its first quarter FY11 results. The company’s Q1 standalone net profit was up 100% at Rs 1,579.39 crore versus Rs.789.83 crore, year-on-year, YoY.

Its Q1 standalone net sales were up 16.51% at Rs 6,471.27 crore versus Rs 5,554.02 crore, YoY.

Q1FY11 consolidated

The company’s consolidated net profit was at Rs 1,825.3 crore versus net loss of Rs 2,208.7 crore, YoY.

Its consolidated net sales were up at Rs 27,010.1 crore versus Rs 23,180.5 crore, YoY..

According to CNBC-TV18 estimates, its consolidated profit after tax was expected at Rs 2,231 crore and consolidated sales were seen at Rs 27544 crore.

Commenting on the results Koushik Chatterjee, Group CFO, Tata Steel said that the company has witnessed good gains in steel prices this month and now prices have slided owing to weak seasonal demand, . On an optimistic note he added that average Indian steel consumption will remain positive.

He explained that the turnover in the April-June quarter was higher on account of increased volumes. Chatterjee added that the next quarter will see large visibility. However he was quick to add that there was an unfortunate fatality in UK this quarter

Buy Allahabad Bank with a stop loss of Rs 197 for a target of Rs 228

Sell Reliance Industries around Rs 977.30-973.70, stop loss Rs 983, cover short at Rs 968.30-959.30

Buy UCO Bank with a stop loss of Rs 95 for a target of Rs 111

Buy Bank of India around Rs 442.80-453.40, stop loss Rs 431, book profit at Rs 473-503.10

Buy JB Chemicals with a stop loss of Rs 97 for a target of Rs 113

Buy Gujarat Heavy Chemicals with a stop loss of Rs 48 for a target of Rs 56

Sell Reliance Industries around Rs 1009.70-998.30, stop loss Rs 1012, cover short at Rs 976.70-943.70

Buy Indiabulls Real Estate around Rs 178-183.20, stop loss Rs 175, book profit at Rs 191-204

Glenmark Pharmaceuticals (BSE Code : 532296) : Glenmark Generics Inc, a US-based subsidiary of the company has received Abbreviated New Drug Application (ANDA) approval from US Food and Drug Administration (USFDA) for Clotrimazole cream USP 1 per cent.The company will commence marketing and distribution of this product in the US market immediately. According to research firm IMS Health, Clotrimazole cream has achieved annual sales of $ 26 million in US for the fiscal ended March this year.Glenmark’s current portfolio consists of 59 products which have been cleared by USFDA for US market. The company has further 50 ANDA’s pending approval with the US health regulator.Glenmark is one of the few pharma stocks which is Funds’ favourite. It is very attractive at this level. Buy immediately.

Dabur India (Rs. 203.00) (Code : 500096) : FMCG player Dabur reported a 20.7 per cent jump in its net profit to Rs 107.39 crore in the quarter ended June 30,2010 and also announced the issue of bonus shares to its shareholders.The company had a net profit of Rs 88.95 crore in the corresponding quarterthe company’s total income stood at Rs 925.11 crore, an increase by 19.7 per cent from Rs 773.05 crore in the year-ago period. growth was mainly led by health supplements category and home care segments, which grew by 42.8 per cent and 31.5 per cent, respectively during the quarter. its oral care category reported a 20.2 per cent growth, the company said its foods business grew by 21.2 per cent. Besides its hair oils and skin care rose by 16.5 per cent and 12.4 per cent during the quarter. The company has also announced 1:1 bonus. It will get momentum as the monsoon is better than expected. Rain fall is much better in July as compared to last 10 years. So, the rural demand will increase for this company’s products.

Eveready Ind. (Rs. ) (Code : 531507) :- For the latest June’10 quarter Eveready Industries posted encouraging result as PAT (excl.extraordinary items) improved by 50% to Rs 22 cr although sales grew marginally to Rs 238 cr. On the back of cost conservation efforts and marginal deferment of advertisement programme helped company record a healthy OPM of more than 15%. Co. has a strong portfolio comprising of dry cell batteries (carbon zinc batteries, rechargeable batteries and alkaline batteries), flashlights (torches), CFLs (Compact Fluorescent Lamps) and packet tea. It’s the undisputed market leader in batteries segment commanding more than 51% market share an 76% in flashlight market in India. Presently company is engaged in enriching its portfolio of LED flashlights by introducing products which are more technologically advanced. With 4000 distributors and a team of 1000 exclusive vans servicing retailers, company boast of having retail enetration exceeding 65% in its class of outlets. Its state-of-the-art manufacturing units are located in Kolkata, Noida, Uttaranchal, Chennai, Lucknow and Maddur. For future growth, company is putting special thrust on its new lighting product business i.e. CFL

JK Paper (Code : 530007)  CMP Rs. – 163.00
J. K. Paper has once again come out with good set of numbers for Q1FY11. PAT zoomed up 45% to Rs 29 cr on 10% higher sales of Rs
291 cr. It posted healthy EPS of almost Rs 4 for June’10 quarter. For FY10, it had reported sales of Rs 1106 cr and net profit of Rs 91 cr i.e. EPS of Rs 12 on which it declared 20% dividend. Over the years, company has emerged as India’s largest producer of branded papers and commands 40% market share in branded cut size papers. Company boasts of having an installed paper production capacity of 2,40,000 TPA and is working at 114% capacity utilization. Even the new paper board unit recorded 118% capacity utilization for FY10. On the raw material front, company has brought over 75,000 hectares under farm forestry in state of Orrisa, Gujarat, AP, Maharashtra, Chattishgarh & WB. As of now it distributes close to 40 million seedlings annually including 5 million high yield cloned varieties developed in-house to over 40,000 farmers. For long term future growth company has decided of putting up a new pulp mill of 200,000 TPA and paper capacity of 150,000 TPA in Orissa itself involving an investment of approx Rs 1500 cr. Scrip can appreciate 25% – 30% within a year.

Buy Century Textiles & Industries with a stop loss of Rs 449 for a target of Rs 520

Buy Sobha Developers with a stop loss of Rs 349 for a target of Rs 404

Sell Reliance Industries around Rs 1004.70-998.30, stop loss Rs 1012, cover short at Rs 987.70-970.70

Fortis Healthcare Q1FY11 consolidated net loss (YoY) stood at Rs 14.3 crore Vs profit of Rs 7.6 crore and net sales stood at Rs 334.2 crore Vs Rs 182.8 crore. OPM stood at 14.06% Vs 15.16% (YoY).

Net interest cost on Parkway acquisition stood at Rs 33 crore. Interest cost stood at Rs 71 crore Vs Rs 10.4 crore. OPM stood at 14.1% Vs 15.2% (YoY). Profit on Parkway stake sale will be accounted in Q2FY11.